Clinical Trials for Hodgkin Lymphoma

Find clinical trials for hodgkin lymphoma. Discover research opportunities and treatment options in your area.

77 Active Trials Found

Showing 77 trials on this page

Page 1 of 4

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

NCT ID: NCT06550427

This clinical trial is studying a new way to evaluate how well treatments are working for patients with aggressive B-cell lymphoma, specifically a type called large B-cell lymphoma (LBCL). The rese...

Recruiting

Type: observational Locations: Taipei, , Taiwan

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

NCT ID: NCT06137144

This clinical trial is studying a new medication called AZD3470, both on its own and when combined with other cancer treatments, for patients with certain types of blood cancers, specifically lymph...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Boston, Massachusetts, United States +18 more

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

NCT ID: NCT05253495

The clinical trial titled "Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma" is studying a new approach to treating certain types of lymphoma, specifically non-Hodgkin lymphoma a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Valhalla, New York, United States, Birmingham, Alabama, United States +3 more

Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer

NCT ID: NCT05550948

This clinical trial is investigating a new treatment approach using light therapy called transcranial photobiomodulation (tPBM) to help improve thinking skills in survivors of childhood cancers, sp...

Recruiting

Phase: NA Type: interventional Locations: Memphis, Tennessee, United States

Improving Exercise Capacity With a Tailored Physical Activity Intervention

NCT ID: NCT05595577

This clinical trial is designed to see if participating in either physical activity sessions or educational workshops can help cancer patients maintain their ability to exercise, support heart func...

Recruiting

Phase: NA Type: interventional Locations: Richmond, Virginia, United States, Winston Salem, North Carolina, United States

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT ID: NCT07020533

This clinical trial is looking at a new vaccine called the CMV-MVA Triplex vaccine, which aims to help patients who are undergoing a type of stem cell transplant called haploidentical hematopoietic...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States, Boston, Massachusetts, United States +1 more

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

NCT ID: NCT06680661

The ABBA CORD clinical trial is designed to test whether adding a medication called abatacept to standard treatments can help prevent a serious complication known as acute graft versus host disease...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cleveland, Ohio, United States

Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy

NCT ID: NCT05977673

This clinical trial is studying the effectiveness and safety of a medication called tislelizumab for patients with a type of cancer known as Hodgkin Lymphoma, who are not able to receive standard c...

Recruiting

Phase: PHASE2 Type: interventional Locations: Alessandria, It, Italy, Aviano, , Italy +8 more

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

NCT ID: NCT03618550

This clinical trial is studying a combination treatment using a drug called pembrolizumab along with a chemotherapy regimen known as GVD for patients with Hodgkin lymphoma that has come back after ...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Miami, Florida, United States +10 more

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

NCT ID: NCT05092451

This clinical trial is exploring a new treatment approach for patients with certain blood cancers, including B-Cell Lymphoma, Myelodysplastic Syndromes (MDS), and Acute Myeloid Leukemia (AML). The ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma

NCT ID: NCT07002216

This clinical trial is investigating a new treatment called BrECADD for patients with Stage 2 B-IV Hodgkin Lymphoma, which is a type of cancer that affects the lymphatic system. The main goal of th...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Miami, Florida, United States

A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.

NCT ID: NCT06383338

The PEGASUS trial is a research study aimed at understanding how certain medications are processed by the body in young patients with Hodgkin or Non-Hodgkin Lymphoma. Specifically, the study is loo...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Melbourne, Victoria, Australia

Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant

NCT ID: NCT05031897

This clinical trial is studying a new way to prepare patients for a type of cancer treatment called hematopoietic stem cell transplant (HSCT). HSCT can help treat certain blood cancers, but sometim...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States

PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma

NCT ID: NCT05922904

This clinical trial is studying the effects of a new treatment combination for patients with classic Hodgkin lymphoma, specifically those who have not received any treatment before and have advance...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

NCT ID: NCT05180097

This clinical trial is examining the effectiveness of two new drugs, Pembrolizumab and Brentuximab Vedotin, compared to standard treatments for patients with relapsed or refractory Hodgkin lymphoma...

Recruiting

Phase: PHASE2 Type: interventional Locations: Calgary, Alberta, Canada, St. John's, Newfoundland And Labrador, Canada +19 more

Early Ageing During Therapy in AYA Cancer Patients

NCT ID: NCT05062707

This clinical trial, titled "Early Ageing During Therapy in AYA Cancer Patients," is studying how cancer treatments affect young adults aged 18 to 39. The researchers want to understand if these tr...

Recruiting

Type: observational Locations: Groningen, , Netherlands, Groningen, , Netherlands

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

NCT ID: NCT06521567

This clinical trial is studying a combination of two medications, cobolimab and dostarlimab, to find out the safest and most effective doses for children and young adults with advanced cancer, spec...

Recruiting

Phase: PHASE1 Type: interventional Locations: Roma, Lazio, Italy, Barcelona, , Spain +35 more

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

NCT ID: NCT04685616

This clinical trial, called RADAR, is studying the effectiveness of two different chemotherapy treatments for patients with early-stage Hodgkin lymphoma. The treatments being compared are ABVD (a s...

Recruiting

Phase: PHASE3 Type: interventional Locations: Winnipeg, Manitoba, Canada, New York, New York, United States +58 more

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

NCT ID: NCT05723055

This clinical trial is investigating a combination of two treatments, nivolumab and axatilimab, for patients with a type of cancer called relapsed or refractory classical Hodgkin lymphoma. This mea...

Recruiting

Phase: PHASE2 Type: interventional Locations: Detroit, Michigan, United States, Salt Lake City, Utah, United States

Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant

NCT ID: NCT03622788

This clinical trial is exploring a new treatment approach using special cells, called cytokine-treated veto cells, for patients with certain blood cancers after they have undergone a stem cell tran...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions